Thank you to our speakers, sponsors, and delegates who joined us in San Diego for the summit! If you are interested in the 2025 event, please get in touch at info@hansonwade.com
Interested To Learn More From Our Experts On Target Selection:
Diversifying Radiopharmaceutical Pipelines by Characterizing Novel Radiopharmaceutical Targets While Expanding the Drug Design Toolkit with Cutting-Edge Targeting, Linker & Chelator Technologies
Brand New 2025 Event Guide:
The Only Meeting Focusing Solely on ADC Targets
Discovering & Validating Novel Targets, to Engineer Precise Target-Linker-Payload Pairings for the Creation of Cutting-Edge, First-In-Class ADCs
The 4th ADC Target Selection Summit
In 2024 the demand for continuous innovation left a great opportunity for biopharma and biotech to shift attention to advanced target selection methods to source novel routes for ADC therapeutic activity.
The 4th ADC Target Selection Summit was created for those professionals seeking to develop a first-in-class ADC through innovation in the target.
In an intimate and discussion-focused environment, speakers honed into the complex mechanistic biology around the target to implement advanced computational approaches to screen potential targets.
Speaker Faculty Included:
Previous Attendees Include:
